Takeda to market new bone cancer drug
May 20, 2009Research and Development, Sales and Marketing MA, Takeda
Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …
Cannabis-derived MS drug filed for European approval
May 20, 2009Research and Development, Sales and Marketing GW, Sativex
Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …
EFPIA plans counterfeit crackdown
May 20, 2009Manufacturing and Production, Research and Development EFPIA, counterfeits
European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …
SkyePharma cuts staff at French and Swiss facilities
May 20, 2009Research and Development, Sales and Marketing Skyepharma
SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …
EU gives the nod to Teva/Lonza biosimilar venture
May 18, 2009Manufacturing and Production, Sales and Marketing Lonza, Teva
The European Commission has given a green light to the formation of a joint venture company between Teva and Lonza …
The medical-marketing interface and how to bridge the gap
May 18, 2009Research and Development, Sales and Marketing marketing, medical
Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …
GSK signs oncology deal with UK biotech
May 18, 2009Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics
GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …
Sanofi-Aventis starts work on dengue fever plant
May 15, 2009Manufacturing and Production Sanofi-Aventis
Sanofi-Aventis' vaccine subsidiary Sanofi Pasteur has broken ground on a 350 million euro facility devoted to the producing a vaccine …
Sanofi-Aventis signs deal with Japanese biotech
May 15, 2009Research and Development, Sales and Marketing Sanofi-Aventis
Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …
Kendle trims down as profits slump
May 15, 2009Research and Development Kendle
Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …
Cohn & Wolfe takes on hepatitis C and substance misuse brief
May 15, 2009Medical Communications Cohn&Wolfe
PR agency Cohn & Wolfe is to handle communications for Schering-Plough's substance misuse and hepatitis C portfolio. It will work …
Boehringer signs diabetes and obesity deal
May 14, 2009Research and Development, Sales and Marketing Boehringer
Boehringer Ingelheim has signed a deal with German biopharma firm DeveloGen to research and develop treatments for diabetes and obesity. …
NHS generic drive saves
May 14, 2009Sales and Marketing NHS
The NHS saved £394 million last year by prescribing cheaper generic medicines, according to an academic study. The Department of …
Does it still pay to be a loyal employee?
May 14, 2009Business Services loyalty, recruitment
Few people can expect to have 'a job for life' anymore, where employees could expect to stay with the same …
Kennedy sets out views on NICE’s future
May 14, 2009Research and Development NICE
Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …
API market growth driven by biologics
May 13, 2009Manufacturing and Production biologics
The global market for active pharmaceutical ingredients is being transformed as big pharma companies devote more and more resources to …
Dragon James Caan invests in CSO Star
May 13, 2009Business Services Star
Star, a specialist contract sales organisation and healthcare recruiter, has won the backing of Dragon's Den investor James Caan. The …
AstraZeneca buoyed as Brilinta tops Plavix in trial
May 13, 2009Research and Development, Sales and Marketing AZ, Brillinta
AstraZeneca has been lifted by clinical results indicating its antiplatelet drug Brilinta outperformed Sanofi-Aventis/Bristol-Myers Squibb’s Plavix – currently the world’s …
Pharma manufacturing: news in brief
May 12, 2009Manufacturing and Production Genzyme
Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new capital investments at Roche, Genzyme and Aeras, …
Latest content
